EUVIMEDEUVIMED entdecken
Open Access

Topical Budesonide for Stricture Prevention following Wide-Field Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasia

Tobias Blasberg, Andreas Wannhoff, Moritz Meiborg, Johannes Richl, Lukas Hiebel, Ardian Mekolli, Ahmad Amanzada, Volker Ellenrieder, Jürgen Hochberger, Karel Caca, Edris Wedi

Visceral Medicine · 27.06.2026 · 1-9

DOI: 10.1159/000553342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Visceral Medicine, online erschienen am 27.06.2026. Verfasst von Tobias Blasberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Esophageal stricture (ES) is a frequent and clinically significant adverse event after wide-field endoscopic submucosal dissection (ESD) for superficial esophageal neoplasia. Despite multiple prophylactic strategies, prevention remains challenging, and current steroid-based regimens offer limited efficacy. This study evaluated the efficacy and safety of budesonide orodispersible tablets (BOT) for ES prevention after wide-field ESD.

Methods

This retrospective, dual-center study evaluated prospectively collected data from patients with superficial esophageal neoplasia undergoing wide-field ESD (≥50% circumferential extent) between August 2020 and August 2024. All patients received BOT (Jorveza® 1 mg twice daily; Dr. Falk Pharma GmbH, Germany) for 4–8 weeks post-ESD. Patients receiving additional stricture-prevention measures were excluded. The primary endpoint was post-ESD stricture. Secondary endpoints included BOT-related adverse events.

Results

Twenty patients (mean age 62.8 ± 10.8 years) underwent ESD with BOT prophylaxis. ES occurred in 35.0% overall – 13.3% after resections involving 50–90% of the esophageal circumference and 100% after circumferential (100%) resections. Patients with strictures had greater circumferential resection extent (85.7% vs. 59.2%; p = 0.036). Four strictures were mild (≤7 dilations) and 3 refractory (≥8). BOT was well tolerated; 2 patients (10.0%) developed asymptomatic esophageal candidiasis, and no systemic steroid-related adverse events occurred.

Conclusion

BOT prophylaxis was well tolerated and may reduce strictures after non-circumferential resections; however, its protective effect appears limited in circumferential resections. Combination strategies may be warranted in high-risk patients.

Schlagwörter

Stichwörter der Autor:innen

Endoscopic submucosal dissectionEsophageal stricture preventionSuperficial esophageal neoplasiaTopical budesonide

Autor:innen und Institutionen

  • Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
  • Department of Gastroenterology, Gastrointestinal Oncology and Interventional Endoscopy, Sana Clinic Offenbach, Offenbach, Germany.
  • Department of Internal Medicine and Gastroenterology, RKH Hospital Ludwigsburg, Ludwigsburg, Germany.
  • Clinic for Gastroenterology, Gastrointestinal Oncology and Endocrinology, University of Göttingen, Göttingen, Germany.

Zitieren

APA

Blasberg, T., Wannhoff, A., Meiborg, M., Richl, J., Hiebel, L., Mekolli, A., Amanzada, A., Ellenrieder, V., Hochberger, J., Caca, K., & Wedi, E. (2026). Topical Budesonide for Stricture Prevention following Wide-Field Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasia. Visceral Medicine, 1-9. https://doi.org/10.1159/000553342

Vancouver

Blasberg T, Wannhoff A, Meiborg M, Richl J, Hiebel L, Mekolli A, et al. Topical Budesonide for Stricture Prevention following Wide-Field Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasia. Visceral Medicine. 2026:1-9. doi:10.1159/000553342

BibTeX
@article{Blasberg2026,
  author = {Blasberg, Tobias and Wannhoff, Andreas and Meiborg, Moritz and Richl, Johannes and Hiebel, Lukas and Mekolli, Ardian and Amanzada, Ahmad and Ellenrieder, Volker and Hochberger, Jürgen and Caca, Karel and Wedi, Edris},
  title = {Topical Budesonide for Stricture Prevention following Wide-Field Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasia},
  journal = {Visceral Medicine},
  year = {2026},
  pages = {1--9},
  doi = {10.1159/000553342}
}
Kostenlos starten →